NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis

Journal of Neuroimmune Pharmacology

Volumn 10, Issue 3, 2015, Pages 435-444

  Dickens, Alex M ^a,b   Larkin, James R ^a   Davis, Benjamin G ^b   Griffin, Julian L ^c   Claridge, Timothy D W ^b   Sibson, Nicola R ^a   Anthony, Daniel C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Diagnostics; Experimental allergic encephalomyelitis; Metabolomics; Mouse; Multiple sclerosis

Indexed keywords

FATTY ACID; GLUCOSE; LACTIC ACID; PHOSPHORYLCHOLINE; TAURINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; METABOLOMICS; MOUSE; MULTIPLE SCLEROSIS; MYCOBACTERIUM BUTYRICUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RECURRENT DISEASE; URINALYSIS; WEIGHT REDUCTION; ANIMAL; BIOZZI MOUSE; BLOOD; DISEASE COURSE; DISEASE MODEL; METABOLISM; PROCEDURES; THEORETICAL MODEL; URINE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MICE; MICE, BIOZZI; MODELS, THEORETICAL; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 84939569349     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-015-9622-0     Document Type: Article

References (40)

1. ‘t Hart BA, Gran B, Weissert R (2011) EAE: imperfect but useful models of multiple sclerosis. Trends Mol Med 17:119–125
2. Ahmed Z, Gveric D, Pryce G, Baker D, Leonard JP, Cuzner ML (2001) Myelin/Axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the lewis rat. Am J Pathol 158:2127–2138
3. Alvord EC Jr (1984) The challenge: how good a model of MS is EAE today? Prog Clin Biol Res 146:3–5
4. Amor S, Smith PA, Bert’t H, Baker D (2005) Biozzi mice: of mice and human neurological diseases. J Neuroimmunol 165:1–10
5. Baker D, O’Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL (1990) Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol 28:261–270
6. Bao Q, Feng J, Chen L, Chen F, Liu Z, Jiang B, Liu C (2013) A robust automatic phase correction method for signal dense spectra. J Magn Reson 234:82–89
7. Barallobre-Barreiro J, Chung Y-L, Mayr M (2013) Proteomics and Metabolomics for Mechanistic Insights and Biomarker Discovery in Cardiovascular Disease. Revista Española de Cardiología (English Edition)
8. Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239–245
9. Bielekova B, Martin R (2004) Development of biomarkers in multiple sclerosis. Brain 127:1463–1478
10. Billiau A, Matthys P (2001) Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 70:849–860
11. Brown A, McFarlin D (1981) Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Laboratory investigation; a journal of technical methods and pathology 45:278–284.
12. Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TDW, Palace J, Anthony DC, Sibson NR (2014) A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology 83:1492–1499
13. Fan WMT (1996) Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog Nucl Magn Reson Spectrosc 28:161–219
14. Fan AY, Lao L, Zhang RX, Zhou AN, Wang LB, Moudgil KD, Lee DYW, Ma ZZ, Zhang WY, Berman BM (2005) Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats. J Ethnopharmacol 101:104–109
15. Giovannoni G, Lai M, Kidd D, Thorpe JW, Miller DH, Thompson AJ, Keir G, Feldmann M, Thompson EJ (1997) Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. Brain 120(Pt 1):1–13
16. Griffin JL, Anthony DC, Campbell SJ, Gauldie J, Pitossi F, Styles P, Sibson NR (2004) Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine. FEBS Lett 568:49–54
17. Hassan-Smith G, Wallace GR, Douglas MR, Sinclair AJ (2012) The role of metabolomics in neurological disease. J Neuroimmunol 248:48–52
18. Heather LC, Wang X, West JA, Griffin JL (2012) A practical guide to metabolomic profiling as a discovery tool for human heart disease. J Mol Cell Cardiol
19. Jackson SJ, Lee J, Nikodemova M, Fabry Z, Duncan ID (2009) Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. J Neuropathol Exp Neurol 68:616–625
20. Kuhle J, Leppert D, Petzold A, Regeniter A, Schindler C, Mehling M, Anthony DC, Kappos L, Lindberg RLP (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology 76:1206–1213
21. Lassmann H (1983) Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis. J Neurol 229:207–220
22. Lindon JC, Holmes E, Nicholson JK (2001) Pattern recognition methods and applications in biomedical magnetic resonance. Prog Nucl Magn Reson Spectrosc 39:1–40
23. Mardiguian S, Serres S, Ladds E, Campbell SJ, Wilainam P, McFadyen C, McAteer M, Choudhury RP, Smith P, Saunders F (2013) Anti–IL-17A treatment reduces clinical score and VCAM-1 expression detected by < i > in Vivo magnetic resonance imaging in chronic relapsing EAE ABH mice. Am J Pathol 182:2071–2081
24. Matsumo Y, Sakuma H, Miyakoshi A, Tsukada Y, Kohyama K, Park IK, Tanuma N (2005) Characterization of relapsing autoimmune encephalomyelitis and its treatment with decoy chemokine receptor genes. J Neuroimmunol 170:49–61
25. Meyer UA, Zanger UM, Schwab M (2013) Omics and drug response. Annu Rev Pharmacol Toxicol 53:475–502
26. Mokhtarian F, McFarlin D, Raine C (1984) Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice
27. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952
28. Ott M, Demisch L, Engelhardt W, Fischer PA (1993) Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing remitting or chronic progressive multiple sclerosis. J Neurol 241:108–114
29. Ransohoff RM (2012) Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat Neurosci 15:1074–1077
30. Salek RM, Xia J, Innes A, Sweatman BC, Adalbert R, Randle S, McGowan E, Emson PC, Griffin JL (2010) A metabolomic study of the CRND8 transgenic mouse model of Alzheimer’s disease. Neurochem Int 56:937–947
31. Serres S, Mardiguian S, Campbell SJ, McAteer MA, Akhtar A, Krapitchev A, Choudhury RP, Anthony DC, Sibson NR (2011) VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. FASEB J
32. Skov T, van den Berg F, Tomasi G, Bro R (2006) Automated alignment of chromatographic data. J Chemom 20:484–497
33. Steinman L, Zamvil SS (2005) Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol 26:565–571
34. Walsh M, Brennan L, Malthouse J, Roche H, Gibney M (2006) Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 84:531
35. Waterman C, Currie R, Cottrell L, Dow J, Wright J, Waterfield C, Griffin J (2010) An integrated functional genomic study of acute phenobarbital exposure in the rat. BMC Genomics 11:9
36. Whitaker JN, McKeehan A, Freeman DW (1994) Monoclonal and polyclonal antibody responses to the myelin basic protein epitope present in human urine. J Neuroimmunol 52:53–60
37. Whitaker JN, Kachelhofer RD, Bradley EL, Burgard S, Layton BA, Reder AT, Morrison W, Zhao GJ, Paty DW (1995) Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis. Ann Neurol 38:625–632
38. Wishart DS et al (2007) HMDB: the Human Metabolome Database. Nucleic Acids Res 35:D521–D526
39. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37:D603
40. Zamvil S, Nelson P, Trotter J, Mitchell D, Knobler R, Fritz R, Steinman L (1985) T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination